BEHANDLUNG VON PROSTATA-KREBS

European patent · EP3247376 · In force

Register entry

Publication number
EP3247376
Application number
EP16771138
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 29, 2016
Published
Nov 29, 2017
Granted
Jul 14, 2021
Protection ends at the latest
Mar 28, 2036
Next annual fee due
Mar 31, 2027
IPC classes
A61K 38/095 (2019.01)
A61K 31/337 (2006.01)
A61P 35/00 (2006.01)
A61P 35/04 (2006.01)
C07D 305/14 (2006.01)
C07K 7/16 (2006.01)
Priority
US 201562139976 P 30.03.2015
PCT application
PCT/CA2016/050362 29.03.2016
PCT publication
WO2016/154748 06.10.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 2, 2024

    Change

    Published in Swissreg on 02.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. May 25, 2022

    Change

    Published in Swissreg on 25.05.2022

  6. Jul 14, 2021

    Granted

    Published in Swissreg on 14.07.2021

Parties

Holder

Sunnybrook Research Institute

2075 Bayview Avenue, Toronto, Ontario M4N 3M5, CA

Inventor

VENKATESWARAN, Vasundara

Toronto, Ontario M1S 1M6, CA

KLOTZ, Laurence H.

Toronto, Ontario M5P 1S3, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.